electroCore (ECOR) Net Income towards Common Stockholders Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | -36.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.73% |
| Dec 31, 2025 | -134.48% |
| Sep 30, 2025 | -36.36% |
| Jun 30, 2025 | -38.27% |
| Mar 31, 2025 | -9.95% |
| Dec 31, 2024 | 317.72% |
| Sep 30, 2024 | 38.07% |
| Jun 30, 2024 | 45.85% |
| Mar 31, 2024 | 40.24% |
| Dec 31, 2023 | 21.00% |
| Sep 30, 2023 | 26.06% |
| Jun 30, 2023 | 8.13% |
| Mar 31, 2023 | -5.11% |
| Dec 31, 2022 | -140.19% |
| Sep 30, 2022 | -36.56% |
| Jun 30, 2022 | -84.42% |
| Mar 31, 2022 | -3.68% |
| Dec 31, 2021 | 285.52% |
| Sep 30, 2021 | 11.00% |
| Jun 30, 2021 | 38.96% |
| Mar 31, 2021 | 32.36% |
| Dec 31, 2020 | 25.59% |
| Sep 30, 2020 | 58.02% |
| Jun 30, 2020 | 60.82% |
| Mar 31, 2020 | 42.58% |
| Dec 31, 2019 | 44.59% |
| Sep 30, 2019 | 19.06% |
| Jun 30, 2019 | 31.95% |
| Mar 31, 2019 | -46.78% |
| Dec 31, 2018 | -167.38% |
| Sep 30, 2018 | -6.81% |
| Jun 30, 2018 | -139.33% |